Literature DB >> 20571222

Clinical and genetic analysis of a Chilean family with early-onset autosomal dominant Alzheimer's disease.

Mariana Sinning1, Jan Piere van Rooyen, Pablo Venegas-Francke, Carolina Vásquez, María Isabel Behrens, Alfredo Ramírez.   

Abstract

Autosomal dominant early-onset Alzheimer's disease (ADEOAD) is associated predominantly with mutations in the genes that codify for presenilin 1 (PSEN1). Only a few ADEOAD families have been reported from Latin America. This is an extended Chilean pedigree affected by ADEOAD along 4 generations. The age of onset of dementia was between 38 and 42 years. Early manifestations were anxiety and depression. Mutation analysis revealed a heterozygous G to C transversion at position 438 of the mRNA in PSEN1 in all affected members. This is the first report of a Chilean family with ADEOAD to include mutation analysis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20571222     DOI: 10.3233/JAD-2010-100135

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  2 in total

1.  Commentary to medical genetics and genomic medicine in Chile: Chilean experience on molecular diagnosis for neurodegenerative disorders.

Authors:  Marcelo Miranda; María Leonor Bustamante
Journal:  Mol Genet Genomic Med       Date:  2017-05-02       Impact factor: 2.183

2.  Dominantly inherited Alzheimer's disease in Latin America: Genetic heterogeneity and clinical phenotypes.

Authors:  Jorge J Llibre-Guerra; Yan Li; Ricardo F Allegri; Patricio Chrem Mendez; Ezequiel I Surace; Juan J Llibre-Rodriguez; Ana Luisa Sosa; Carmen Aláez-Verson; Erika-Mariana Longoria; Alberto Tellez; Karol Carrillo-Sánchez; Luis Leonardo Flores-Lagunes; Victor Sánchez; Leonel Tadao Takada; Ricardo Nitrini; Norberto Anizio Ferreira-Frota; Joyce Benevides-Lima; Francisco Lopera; Laura Ramírez; Ivonne Jiménez-Velázquez; Christian Schenk; Daisy Acosta; María Isabel Behrens; Michelle Doering; Ellen Ziegemeier; John C Morris; Eric McDade; Randall J Bateman
Journal:  Alzheimers Dement       Date:  2020-11-23       Impact factor: 21.566

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.